+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
The worldwide biliary tumor market is anticipated to witness a consistent increase in revenue Compound Annual Growth Rate (CAGR) throughout the forecast period. The primary drivers for this market growth include the escalating global incidence of Bile Duct Cancer, advancements in healthcare technology, and the rising healthcare costs in developed nations.
Bile duct cancer, or cholangiocarcinoma, originates in the tubes connecting the liver, gallbladder, and small intestine. Intrahepatic bile duct cancer occurs within the liver, while extrahepatic bile duct carcinoma occurs outside the liver. The intricate network of tubes, known as bile ducts, facilitates the passage of bile from the liver and gallbladder to the small intestine, aiding in lipid digestion. Bile duct cancer can manifest in any part of this system.
According to the National Organization for Rare Disorders and the American Cancer Society, the U.S. witnesses approximately 1 case of perihilar cholangiocarcinoma per 100,000 individuals annually.
Bile duct carcinoma affects 8,000 to 10,000 people in the U.S. annually, with typical diagnosis ages of 70 for intrahepatic and 72 for extrahepatic bile duct carcinoma.
The survival rates vary, with 10% survival after five years for extrahepatic cases, and only 2% survival after five years if the cancer has spread to other areas.
The elevated cost of current treatments is anticipated to impede revenue growth.
The lack of novel treatment methods and unfavorable side effects related to cancer therapy are also significant challenges.
Opportunities exist for market participants to enhance healthcare quality and develop novel technologies for diagnosis.
Various research projects are underway to simplify cancer treatment, presenting potential opportunities in the bile duct cancer market.
North America is projected to exhibit the highest revenue CAGR due to increased incidence of Advanced Renal Cell Carcinoma and accessibility to novel technology in cancer research and treatment facilities.
The U.S. alone witnesses about 8,000 new cases of bile duct tumors annually.
The Asia Pacific region is expected to experience steady revenue growth during the forecast period due to heightened awareness campaigns, public and private investments, and a streamlined manufacturing approval process.
· In January 2022, the FDA approved Compass Therapeutics' global Phase 2 clinical trial for CTX-009, a treatment for advanced biliary tract cancers.
· In July 2022, AstraZeneca initiated a phase 3 clinical study of Durvalumab in combination with Gemcitabine/Cisplatin for advanced biliary tract cancer.
· In March 2021, Pemazyre (pemigatinib) received approval from the European Commission for the treatment of cholangiocarcinoma.
· In January 2020, Sirnaomics Inc. and Innovent Biologics, Inc. partnered for the development of combination treatment for advanced cancers.
· In April 2020, Pemazyre received accelerated FDA approval for certain forms of advanced cholangiocarcinoma.
· Incyte Corporation
· Eisai Co., Ltd
· QED Therapeutics, Inc
· Agios Pharmaceuticals, Inc
· RenovoRx
· Ability Pharmaceuticals
· Imbrium Therapeutics L.P
· Delcath Systems, Inc.
· Chemotherapy
· Immunotherapy
· Targeted Therapy
· Other
· Oral
· Parenteral
· Other
· Online Channel
· Offline Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· North America
· Europe
· Asia-Pacific
· Latin America
· Middle East & Africa
This report furnishes verifiable data, projections, and revenue growth analysis at global, regional, and national levels. It includes detailed analysis of industry trends, drivers, constraints, opportunities, threats, market strategies, segment revenue, and market share for each region and nation from 2019 to 2030. The report also offers industry analysis, a competitive landscape, company financials, and impact analysis. It provides a comprehensive view of the global market, encompassing dynamic trends, scenarios, detailed market and regional segmentation, regional landscapes, analysis and evaluation, major investments, product offerings, product launches, and historical, current, and projected revenue details.
The worldwide biliary tumor market is anticipated to witness a consistent increase in revenue Compound Annual Growth Rate (CAGR) throughout the forecast period.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65469
Published on :
Upcoming
Request a Free Sample Report
Speak to Analyst